Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 Slide Shows
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
CES 2010 Coverage 

Follow Us
RTTNews on Twitter RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube

Eli Lilly And Co.(LLY)

Trade LLY now with

RTTNews Articles

Eli Lilly Says Cymbalta Significantly Reduced Chronic Low Back Pain - Quick Facts
2/3/2010 8:17:15 AM     RTT News
Eli Lilly Says Cymbalta Significantly Reduced Chronic Low Back Pain In New Study
2/3/2010 8:04:24 AM     RTT News
Credit Suisse Is Lowering Eli Lilly And Co. (LLY) 2011 Estimate To 4.72 From 4.73
1/29/2010 10:43:23 AM     RTT News
Eli Lilly Turns To Profit In Q4; Backs 2010 Forecast
1/28/2010 8:54:45 AM     RTT News
Eli Lilly Q4 09 Earnings Conference Call At 9:00 AM ET
1/28/2010 8:15:17 AM     RTT News
Eli Lilly Swings To Q4 Profit; Backs FY10 EPS View - Quick Facts
1/28/2010 6:45:21 AM     RTT News
Eli Lilly Q4 09 Earnings Conference Call At 9:00 AM ET
1/28/2010 6:40:05 AM     RTT News
Eli Lilly Reports Q4 Pro Forma Non-GAAP EPS Of $0.91 Vs. $1.02 Prior Year
1/28/2010 6:32:04 AM     RTT News
Transition Therapeutics Reports Positive Result For Phase II Study Of TT-223 In Type 2 Diabetes - Update
1/25/2010 8:24:58 AM     RTT News
Earnings Season Gaining Momentum
1/25/2010 3:18:02 AM     RTT News
Eli Lilly CEO John Lechleiter Stresses Human Element In Driving Medical Innovation
1/14/2010 3:01:09 PM     RTT News
Lilly's Cymbalta Not Out Of Pain - FDA Cancels Advisory Committee Meeting
1/6/2010 4:11:45 AM     RTT News
Eli Lilly's Blood Thinner Prasugrel Shows Cost Effectiveness In Study - Update
1/5/2010 11:25:06 AM     RTT News
Eli Lilly Says Study Showed Effient Cost-Effective Vs. Clopidogrel For Patients With Acute Coronary Syndromes Undergoing PCI - Quick Facts
1/5/2010 9:29:24 AM     RTT News
Eli Lilly Says New Analysis Showed Effient Cost-Effective Compared With Clopidogrel For Patients With Acute Coronary Syndromes Undergoing PCI
1/5/2010 9:07:00 AM     RTT News
Boston Scientific Begins Post-Approval Stent Study
1/4/2010 11:10:10 AM     RTT News
Boston Scientific Enrolls First Patient In Its TAXUS Liberte Post-approval Study
1/4/2010 8:31:37 AM     RTT News
Lilly, Kowa To Co-Promote Livalo - Update
12/23/2009 12:41:38 PM     RTT News
Eli Lilly, Kowa And Kowa Pharmaceuticals America Announce Co-Promotion And Licensing Agreement
12/23/2009 10:53:55 AM     RTT News
Eli Lilly, Kowa And Kowa Pharmaceuticals America Enter Co-Promotion And Licensing Deal - Quick Facts
12/23/2009 10:10:15 AM     RTT News
 
Previous 20 Headlines
  
 
 

 

Copyright © 2010 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service| How To Use RTTNews.com| Advertise| Privacy| Buy Content | RSS